Open tender · Germany · Cn Standard
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fondaparinux (ATC-Code: B01AX05).
AOK Niedersachsen. Die Gesundheitskasse.
The work
Conclusion of a non-exclusive discount contract for the active substance Fondaparinux (ATC-Code: B01AX05) for the AOK Niedersachsen from 01.01.2025 to 31.12.2026.
- Must be a pharmaceutical entrepreneur as per § 4 Abs. 18 AMG.
- The contract is non-exclusive and open to all market participants.
- The contract is for the active substance Fondaparinux (ATC-Code: B01AX05).
- The contract period is from 01.01.2025 to 31.12.2026.
Key facts
- Contract period
- The contract period is from 01.01.2025 to 31.12.2026, with a maximum contract duration of 24 months.
- Evaluation
- The tender is not a public procurement in the sense of the Directive 2014/24/EU.
What it takes to qualify
Worth a closer look
- The tender is not a public procurement in the sense of the Directive 2014/24/EU or the procurement law.
Experience
- At least 1 similar work — No specific experience requirements mentioned.
Certifications and registrations
GST registrationNo mention of GST registration in the provided text.
PAN registrationNo mention of PAN registration in the provided text.
EPF registrationNo mention of EPF registration in the provided text.
ESIC registrationNo mention of ESIC registration in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Contractual documents and conditionsRequested to be requested from the AOK Niedersachsen.
- Proof of being a pharmaceutical entrepreneurMust be a pharmaceutical entrepreneur as per § 4 Abs. 18 AMG.